SB-3CT - Moligand™, 10mM in DMSO , Inhibitor of MMP2;Inhibitor of MMP9, CAS No.292605-14-2, Inhibitor of MMP2;Inhibitor of MMP9

CAS: 292605-14-2 Cat. No.: S408624 Formula: C15H14O3S2 Molecular Weight: 306.4 EC Number: 684-085-5 PubChem CID: 9883002
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Size
Germany (EU)
USA*
Price
Qty
1ml
S408624-1ml
—
2 In stock

€178.67

€260.23
Save €81.57 (31.34%)
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

SB-3CT SB-3CT is an effective and selective gelatinase inhibitor with K i of 13.9 nM and 600 nM for MMP-2 and MMP-9 , respectively.
In vitro

SB-3CT directly inhibits bone marrow endothelial cell invasion and tubule formation in Matrigel in vitro.

In vivo

In L-CI.5s T-cell lymphoma model, SB-3CT (5-50 mg/kg/d i.p.) potently inhibit liver metastasis and increases survival of mice. SB-3CT (50 mg/kg/d i.p.) inhibits human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model. In a mouse model of embolus-induced “permanent” focal cerebral ischemia, SB-3CT counteracts degradation of neuronal laminin, protects neurons from ischemic cell death, and ameliorates neurobehavioral outcomes after embolic MCA occlusion.
Cell Data

cell lines:A10 cells (Vascular SMC)

Concentrations:

Incubation Time:

Powder Purity:≥97%

Specifications

Synonyms
2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane
Specifications & Purity
Moligand™, 10mM in DMSO
Biochemical and Physiological Mechanisms
SB-3CT is an effective and selective gelatinase inhibitor with Ki of 13.9 nM and 600 nM for MMP-2 and MMP-9, respectively.
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of MMP2;Inhibitor of MMP9
Names and Identifiers
Isomeric SMILES C1C(S1)CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=CC=C3
PubChem CID 9883002
Molecular Weight 306.4

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Associated Targets(Human)
MMP14 Tchem Matrix metalloproteinase-14 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP9 Tchem Matrix metalloproteinase-9 (6 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MMP2 Tchem 72 kDa type IV collagenase (6 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilitySolubility (25°C) In vitro DMSO: 100 mg/mL (97.06 mM); Ethanol: 100 mg/mL (97.06 mM); Water: Insoluble;
x_melt_point_char101 °C
FAQs and Articles
Citations of This Product
References
1. Xiao-lei ZHANG, Meng-ni HU, Ya-nan LI, Yao WANG, Zhen RONG, Jun MA.  (2025)  Effect of electroacupuncture on MMP-2/9 pathway mediated the blood-brain barrier permeability in mice with Parkinson's disease.  World Journal of Acupuncture-Moxibustion,      [PMID:] [10.1016/j.wjam.2025.01.002]
Solution Calculators
Reviews

Customer Reviews

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.